» Articles » PMID: 35303586

Lacticaseibacillus Rhamnosus Modulates the Inflammatory Response and the Subsequent Lung Damage in a Murine Model of Acute Lung Inflammation

Overview
Publisher Elsevier
Specialty General Medicine
Date 2022 Mar 18
PMID 35303586
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The present study investigated the anti-inflammatory effect of the probiotic Lacticaseibacillus rhamnosus (Lr) on lung inflammation induced by Lipopolysaccharide (LPS) of Escherichia coli in C57BL/6 mice.

Methods: C57BL/6 mice were divided into four groups: control, LPS, Lr (1 day) + LPS, and Lr (14 days) + LPS. Total and differential cells from Bronchoalveolar Lavage Fluid (BALF) were counted in a Neubauer 40X chamber, and pro-and anti-inflammatory cytokines (IL-1β, IL-6, CXCL-1, TNF-α, TGF-β, and IL-10) were measured by ELISA assay. The analysis of whole leukocytes in blood was performed using the automated system Sysmex 800i. Morphometry of pulmonary tissue evaluated alveolar hemorrhage, alveolar collapse, and inflammatory cells. Pulmonary vascular permeability was assessed by Evans blue dye extravasation, and bronchoconstriction was evaluated in a tissue bath station. The transcription factor NF-kB was evaluated by ELISA, and its gene expression and TLR-2, TLR-4, MMP-9, MMP-12, and TIMP by PCR.

Results: The probiotic Lr had a protective effect against the inflammatory responses induced by LPS. Lr significantly reduced pro-inflammatory cells in the airways, lung parenchyma, and blood leukocytes. Furthermore, Lr reduced the production of pro-inflammatory cytokines and chemokines in BALF and the expression of TLRs, MMPs, and NF-kB in lung tissue and maintained the expression of TIMP in treated animals promoting a protective effect on lung tissue.

Conclusions: The results of the study indicate that pre-treatment with the probiotic Lr may be a promising way to mitigate lung inflammation in endotoxemia.

Citing Articles

The Microbiota-Gut-Brain Axis: Key Mechanisms Driving Glymphopathy and Cerebral Small Vessel Disease.

Che Mohd Nassir C, Che Ramli M, Ghazali M, Jaffer U, Abdul Hamid H, Mehat M Life (Basel). 2025; 15(1).

PMID: 39859943 PMC: 11766513. DOI: 10.3390/life15010003.


Dual Functioned Hexapeptide-Coated Lipid-Core Nanomicelles Suppress Toll-Like Receptor-Mediated Inflammatory Responses through Endotoxin Scavenging and Endosomal pH Modulation.

Ji Y, Sun L, Liu Y, Li Y, Li T, Gong J Adv Sci (Weinh). 2023; 10(19):e2301230.

PMID: 37078808 PMC: 10323664. DOI: 10.1002/advs.202301230.

References
1.
Hakonarson H, Maskeri N, Carter C, Grunstein M . Regulation of TH1- and TH2-type cytokine expression and action in atopic asthmatic sensitized airway smooth muscle. J Clin Invest. 1999; 103(7):1077-87. PMC: 408262. DOI: 10.1172/JCI5809. View

2.
Wu C, Chen P, Lee Y, Ko J, Lue K . Effects of immunomodulatory supplementation with Lactobacillus rhamnosus on airway inflammation in a mouse asthma model. J Microbiol Immunol Infect. 2014; 49(5):625-635. DOI: 10.1016/j.jmii.2014.08.001. View

3.
Zocco M, Zileri Dal Verme L, Cremonini F, Piscaglia A, Nista E, Candelli M . Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther. 2006; 23(11):1567-74. DOI: 10.1111/j.1365-2036.2006.02927.x. View

4.
Wang J, Li R, Peng Z, Hu B, Rao X, Li J . HMGB1 participates in LPS‑induced acute lung injury by activating the AIM2 inflammasome in macrophages and inducing polarization of M1 macrophages via TLR2, TLR4, and RAGE/NF‑κB signaling pathways. Int J Mol Med. 2019; 45(1):61-80. PMC: 6889921. DOI: 10.3892/ijmm.2019.4402. View

5.
Aschner Y, Zemans R, Yamashita C, Downey G . Matrix metalloproteinases and protein tyrosine kinases: potential novel targets in acute lung injury and ARDS. Chest. 2014; 146(4):1081-1091. PMC: 4188143. DOI: 10.1378/chest.14-0397. View